Cabaletta Bio, Inc. Profile Avatar - Palmy Investing

Cabaletta Bio, Inc.

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor…

Biotechnology
US, Philadelphia [HQ]